/ Simparica

Simparica (sarolaner) Chewables Dogged Protection

Simparica Kills Ticks 2-11

Ticks are more than just a nuisance. They can transmit disease! 
Help protect your dog with Simparica.

Tick Performance

Sarolaner starts killing ticks within 8 hours and keeps going strong for 35 days without losing effectiveness at the end of the month. This is important to help reduce the risk of transmission of potentially life-threatening tick-borne diseases.

Tick Prevalence

Tick-borne diseases represent a widespread and growing public health hazard to dogs (and their human companions), causing debilitating illness and even death. It only takes one tick to spread disease, so continuous protection is critical to help reduce the risk of infection.

Why switch to Simparica? Why switch to Simparica?

IMPORTANT SAFETY INFORMATION: Simparica is for use only in dogs, 8 weeks of age and older. Simparica has not been evaluated in dogs that are pregnant, breeding or lactating.

References: 2. National Institute of Allergy and Infectious Disease. Tickborne diseases. http://www.niaid.nih.gov/topics/tickborne/Pages/Default.aspx. Accessed January 16, 2017. 3. Six RH, Geurden T, Carter L, et al. Evaluation of the speed of kill of sarolaner (Simparica™) against induced infestations of three species of ticks (Amblyomma maculatum, Ixodes scapularis, Ixodes ricinus) on dogs. Vet Parasitol. 2016;222:37-42. 4. Six RH, Everett WR, Young DR, et al. Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States. Vet Parasitol. 2016;222:28-32. 5. Honsberger NA, Six RH, Heinz TJ, et al. Efficacy of sarolaner in the prevention of Borrelia burgdorferi and Anaplasma phagocytophilum transmission from infected Ixodes scapularis to dogs. Vet Parasitol. 2016; 222:67-72. 6. Companion Animal Parasite Council. Current advice on parasite control: ectoparasites – ticks. https://www.capcvet.org/capc-recommendations/ticks/. Updated June 2015. Accessed January 23, 2016. 7. Yale School of Public Health. Mapping Lyme disease enzootic risk and linking to disease outcomes in the United States. https://publichealth.yale.edu/emd/research/zoonosis/projects/tick.aspx. Accessed December 9, 2016. 8. Centers for Disease Control and Prevention. Tick-borne diseases of the United States – a reference manual for health care providers. Third edition. https://www.cdc.gov/lyme/resources/tickbornediseases.pdf. Updated 2015. Accessed January 24, 2017. 9. Life cycle of hard ticks that spread disease. Centers for Disease Control and Prevention website. https://www.cdc.gov/ticks/life_cycle_and_hosts.html. Updated June 1, 2015. Accessed January 23, 2017. 10. Little SE. Changing paradigms in understanding transmission of canine tick-borne diseases: the role of interrupted feeding and intrastadial transmission. In: Proceedings of the 2nd Canine Vector-Borne Disease (CVBD) Symposium; April 25-28, 2007; Sicily, Italy. 10. Geographic distribution of ticks that bite humans. 11. Centers for Disease Control and Prevention website. http://www.cdc.gov/ticks/geographic_distribution.html. Updated June 1, 2015. Accessed December 9, 2016.

Site Map   Privacy Policy   Terms of Use

For animal use only.

SIMPARICA 5 mg (chewable tablets for dogs). Reg. No.: G4317 (Act 36/1947).  Each chewable tablet contains 5 mg sarolaner. SIMPARICA 10 mg (chewable tablets for dogs). Reg. No.: G4322 (Act 36/1947).  Each chewable tablet contains 10 mg sarolaner. SIMPARICA 20 mg (chewable tablets for dogs). Reg. No.: G4318 (Act 36/1947).  Each chewable tablet contains 20 mg sarolaner.  SIMPARICA 40 mg (chewable tablets for dogs). Reg. No.: G4319 (Act 36/1947).  Each chewable tablet contains 40 mg sarolaner.      SIMPARICA 80 mg (chewable tablets for dogs). Reg. No.: G4320 (Act 36/1947).  Each chewable tablet contains 80 mg sarolaner. SIMPARICA 120 mg (chewable tablets for dogs). Reg. No.: G4321 (Act 36/1947).  Each chewable tablet contains 120 mg sarolaner.  For “WARNINGS” refer to the approved package insert.  For full prescribing information refer to the package insert approved by the medicines regulatory authority.

Full product information available from Zoetis South Africa (Pty) Ltd., Co. Reg. No.: 2012/001825/07. 6th Floor, North Wing, 90 Rivonia Road, Sandton, 2196. PostNet Suite 53, Private Bag 9976, Sandton, 2146, South Africa. Tel.: +27 11 245 3300 or 0860 ZOETIS (0860 963847). www.zoetis.co.za